BRPI0925056A2 - medicamento mastigável - Google Patents

medicamento mastigável

Info

Publication number
BRPI0925056A2
BRPI0925056A2 BRPI0925056A BRPI0925056A BRPI0925056A2 BR PI0925056 A2 BRPI0925056 A2 BR PI0925056A2 BR PI0925056 A BRPI0925056 A BR PI0925056A BR PI0925056 A BRPI0925056 A BR PI0925056A BR PI0925056 A2 BRPI0925056 A2 BR PI0925056A2
Authority
BR
Brazil
Prior art keywords
chewable medicine
chewable
medicine
Prior art date
Application number
BRPI0925056A
Other languages
English (en)
Inventor
Judy Davis
Original Assignee
Hero Nutritionals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hero Nutritionals Llc filed Critical Hero Nutritionals Llc
Publication of BRPI0925056A2 publication Critical patent/BRPI0925056A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0925056A 2009-06-24 2009-08-26 medicamento mastigável BRPI0925056A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22011109P 2009-06-24 2009-06-24
US12/547,355 US20100330058A1 (en) 2009-06-24 2009-08-25 Chewable drug
PCT/US2009/055041 WO2010151275A1 (en) 2009-06-24 2009-08-26 Chewable drug

Publications (1)

Publication Number Publication Date
BRPI0925056A2 true BRPI0925056A2 (pt) 2015-11-24

Family

ID=43381015

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0925056A BRPI0925056A2 (pt) 2009-06-24 2009-08-26 medicamento mastigável

Country Status (6)

Country Link
US (1) US20100330058A1 (pt)
EP (1) EP2445485A4 (pt)
BR (1) BRPI0925056A2 (pt)
CA (1) CA2766908A1 (pt)
MX (1) MX2012000132A (pt)
WO (1) WO2010151275A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014227406A (ja) * 2013-05-27 2014-12-08 株式会社ウメケン 苦味生薬含有粒状物
WO2015042723A1 (en) 2013-09-30 2015-04-02 Iaf Science Holdings Ltd. Chewable product and process for making same
US11154495B2 (en) 2015-04-07 2021-10-26 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
AU2017216928B2 (en) * 2016-02-11 2018-09-20 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof
JP6877923B2 (ja) * 2016-09-06 2021-05-26 ライオン株式会社 内服用半固形製剤及びその製造方法
US10960076B2 (en) 2017-01-25 2021-03-30 Church & Dwight Co. Inc. Gummy dosage forms comprising serine
GB201801994D0 (en) * 2018-02-07 2018-03-28 Ubeauty Global A tanning composition
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
US12390416B2 (en) 2018-07-18 2025-08-19 USpharma Ltd Chewable pharmaceutical dosage forms
US11350657B2 (en) 2018-08-06 2022-06-07 Pharmavite, Llc Protein gummy composition
US20220339097A1 (en) 2021-04-27 2022-10-27 Gelita Ag Discontinuous gummy delivery systems
WO2026015433A1 (en) * 2024-07-08 2026-01-15 Bayer Healthcare Llc In situ preparation of gummy compositions in blister

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950689A (en) * 1987-03-31 1990-08-21 Yang Robert K Pectin delivery system
US4800096A (en) * 1987-05-29 1989-01-24 General Foods Corporation Pectin gelling composition
AU730126B2 (en) * 1995-12-26 2001-02-22 Medtech Products, Inc. Dietary fiber delivery system
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
US6241997B1 (en) * 1998-03-16 2001-06-05 Smtm Group. Llc Chewable calcium supplement and method
US5955102A (en) * 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
US6193999B1 (en) * 1999-03-01 2001-02-27 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules
US6340471B1 (en) * 1999-12-30 2002-01-22 Alvin Kershman Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US20070292517A1 (en) * 2004-04-01 2007-12-20 Scepter Holdings, Inc. Delivery Systems for Antacids
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof

Also Published As

Publication number Publication date
EP2445485A1 (en) 2012-05-02
CA2766908A1 (en) 2010-12-29
US20100330058A1 (en) 2010-12-30
MX2012000132A (es) 2012-05-08
EP2445485A4 (en) 2013-08-28
WO2010151275A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
BRPI1013639A2 (pt) medicamentos antidiabéticos
BRPI0920521A2 (pt) combinação farmacêutica
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
EP2469625A4 (en) OMNIBUS BAR
EP2445547A4 (en) CATHETERISM SYSTEM
DK2430035T3 (da) Uracylspipooxetannukleosider
SMT201400069B (it) Formulazione farmaceutica
BRPI0925056A2 (pt) medicamento mastigável
NO20083238L (no) Narresmokk
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
FI20095433A0 (fi) Mikroneula
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
EP2409976A4 (en) GLYCINE TRANSPORTER INHIBITOR
BRPI0922653A2 (pt) preparação farmacêutica
EP2508411A4 (en) STRUCTURE
DK2483126T3 (da) Skinnekøretøj
DE112010004865T8 (de) Lamellennassreibkupplung
BR112013008074A2 (pt) combinações farmacêuticas
DK2506968T3 (da) Faujasit-zeolit

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.